Cross-talk between FGF and other cytokine signalling pathways during endochondral bone development

Cell Biology International

Volumn 36, Issue 8, 2012, Pages 691-696

  Jin, Min ^a   Du, Xiaolan ^a   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cross talk; Endochondral bone development; Fgf; Fgfr; Signalling pathway

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

CARTILAGE CELL; CELL DIFFERENTIATION; CELL TYPE; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; GENE INACTIVATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OSTEOBLAST; PLEIOTROPY; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; CYTOKINES; FIBROBLAST GROWTH FACTORS; HEDGEHOG PROTEINS; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84865074621     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110352     Document Type: Review

References (85)

1. Ambrosetti D, Holmes G, Mansukhani A, Basilico C. Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol Cell Biol 2008;28:4759-71.
2. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005;5:921-9.
3. Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995;172:126-38.
4. Bottcher RT, Pollet N, Delius H, Niehrs C. The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat Cell Biol 2004;6:38-44.
5. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
6. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV et al. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999;104:1517-25.
7. Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci 2005;10:1961-76.
8. Chen L, Li C, Qiao W, Xu X, Deng C. A Ser(365)- Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet 2001;10:457-65.
9. Choi KY, Kim HJ, Lee MH, Kwon TG, Nah HD, Furuichi T et al. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 2005;233:115-21.
10. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 2008;17:725-36.
11. Christofori G. Split personalities: the agonistic antagonist Sprouty. Nat Cell Biol 2003;5:377-9.
12. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996;12:390-7.
13. Dailey L, Laplantine E, Priore R, Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 2003;161:1053-66.
14. Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, Mascarelli F et al. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-cateninindependent signaling pathway. Exp Cell Res 2004;297:235-46.
15. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996;84:911-21.
16. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-84.
17. Enomoto-Iwamoto M, Nakamura T, Aikawa T, Higuchi Y, Yuasa T, Yamaguchi A et al. Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation. J Bone Miner Res 2000;15:1659-68.
18. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005;16:139-49.
19. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002;129:3783-93.
20. Eswarakumar VP, Ozcan F, Lew ED, Bae JH, Tome F, Booth CJ et al. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci USA 2006;103:18603-8.
21. Fujita T, Fukuyama R, Enomoto H, Komori T. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J Cell Biochem 2004;93:374-83.
22. Furthauer M, Lin W, Ang SL, Thisse B, Thisse C. Sef is a feedbackinduced antagonist of Ras/MAPK-mediated FGF signalling. Nat Cell Biol 2002;4:170-4.
23. Grotewold L, Ruther U. Bmp, Fgf and Wnt signalling in programmed cell death and chondrogenesis during vertebrate limb development: the role of Dickkopf-1. Int J Dev Biol 2002;46:943-7.
24. Hall BK, Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000;22:138-47.
25. Hanafusa H, Torii S, Yasunaga T, Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002;4:850-8.
26. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
27. Henderson BR, Fagotto F. The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 2002;3:834-9.
28. Hidaka K, Kanematsu T, Takeuchi H, Nakata M, Kikkawa U, Hirata M. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5. Int J Biochem Cell Biol 2001;33:1094-103.
29. Iwasaki M, Le AX, Helms JA. Expression of indian hedgehog, bone morphogenetic protein 6 and gli during skeletal morphogenesis. Mech Dev 1997;69:197-202.
30. Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA et al. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 2000;9:1603-13.
31. Iwata T, Li CL, Deng CX, Francomano CA. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum Mol Genet 2001;10:1255-64.
32. Jacob AL, Smith C, Partanen J, Ornitz DM. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 2006;296:315-28.
33. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002;2:389-406.
34. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y et al. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 2000;96:2005-11.
35. Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 2003;34:303-7.
36. Koike M, Yamanaka Y, Inoue M, Tanaka H, Nishimura R, Seino Y. Insulinlike growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK. J Bone Miner Res 2003;18:2043-51.
37. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332-6.
38. Kubota K, Iseki S, Kuroda S, Oida S, Iimura T, Duarte WR et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 2002;31:465-71.
39. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A et al. PTH/PTHrP receptor in early development and Indian hedgehogregulated bone growth. Science 1996;273:663-6.
40. Laufer E, Nelson CE, Johnson RL, Morgan BA, Tabin C. Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell 1994;79:993-1003.
41. Lee K, Deeds JD, Segre GV. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 1995;136:453-63.
42. Linsenmayer TF, Chen QA, Gibney E, Gordon MK, Marchant JK, Mayne R et al. Collagen types IX and X in the developing chick tibiotarsus: analyses of mRNAs and proteins. Development 1991;111:191-6.
43. Malbon CC. Frizzleds: new members of the superfamily of G-proteincoupled receptors. Front Biosci 2004;9:1048-58.
44. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 2005;168:1065-76.
45. Maruyama T, Mirando AJ, Deng CX, Hsu W. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 2010;3:ra40.
46. Matsushita T, Wilcox WR, Chan YY, Kawanami A, Bukulmez H, Balmes G et al. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Hum Mol Genet 2009;18:227-40.
47. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 2002;3:439-49.
48. Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002;296:1644-6.
49. Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci 2005;118:3573-84.
50. Naganawa T, Xiao L, Coffin JD, Doetschman T, Sabbieti MG, Agas D et al. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 2008;103:1975-88.
51. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 2005;36:399-407.
52. Naski MC, Ornitz DM. FGF signaling in skeletal development. Front Biosci 1998;3:d781-94.
53. Niswander L. Pattern formation: old models out on a limb. Nat Rev Genet 2003;4:133-43.
54. Oh CD, Chun JS. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulinlike growth factor-1. J Biol Chem 2003;278:36563-71.
55. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2:REVIEWS3005.
56. Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002;16:1446-65.
57. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003;17:1352-65.
58. Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 2003;17:3023-8.
59. Perlyn CA, Morriss-Kay G, Darvann T, Tenenbaum M, Ornitz DM. A model for the pharmacological treatment of Crouzon syndrome. Neurosurgery 2006;59:210-5; discussion 210-5.
60. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-97.
61. Priore R, Dailey L, Basilico C. Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J Cell Physiol 2006;207:800-8.
62. Qureshi HY, Ahmad R, Sylvester J, Zafarullah M. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell Signal 2007;19:1643-51.
63. Retting KN, Song B, Yoon BS, Lyons KM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009;136:1093-104.
64. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008;133:403-14.
65. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 2007;25:441-54.
66. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 2007;39:1145-50.
67. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999;13:2072-86.
68. Starkman BG, Cravero JD, Delcarlo M, Loeser RF. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem J 2005;389:723-9.
69. Su N, Du X, Chen L. FGF signaling: its role in bone development and human skeleton diseases. Front Biosci 2008;13:2842-65.
70. Tanaka E, Ishino Y, Sasaki A, Hasegawa T, Watanabe M, Dalla-Bona DA et al. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Ann Biomed Eng 2006;34:717-25.
71. ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development 2008;135:3247-57.
72. Tickle C, Munsterberg A. Vertebrate limb development-the early stages in chick and mouse. Curr Opin Genet Dev 2001;11:476-81.
73. Tsang M, Friesel R, Kudoh T, Dawid IB. Identification of Sef, a novel modulator of FGF signalling. Nat Cell Biol 2002;4:165-9.
74. Tuan RS. Biology of developmental and regenerative skeletogenesis. Clin Orthop Relat Res 2004:S105-17.
75. Valverde-Franco G, Liu H, Davidson D, Chai S, Valderrama-Carvajal H, Goltzman D et al. Defective bone mineralization and osteopenia in young adult FGFR32/2 mice. Hum Mol Genet 2004;13:271-84.
76. Verheyden JM, Sun X. An Fgf/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth. Nature 2008;454:638-41.
77. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996;273:613-22.
78. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93:411-22.
79. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-9.
80. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD et al. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 2004;279:27743-52.
81. Yang G, Sun Q, Teng Y, Li F, Weng T, Yang X. PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress. Development 2008;135:3587-97.
82. Yang ZZ, Tschopp O, Di-Poi N, Bruder E, Baudry A, Dummler B et al. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 2005;25:10407-18.
83. Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J Cell Biochem 2004;93:93-103.
84. Yoon BS, Pogue R, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR et al. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 2006;133:4667-78.
85. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 2003;130:3063-74.